Next Generation Sequencing
Next Generation Sequencing (NGS) technologies are able to analyze millions to billions of DNA sequences in parallel, offering unprecedented amounts of genetic information and degree of sensitivity. With its cost dropping at a consistent rate over the last decade, NGS not only becomes increasingly popular in scientific research but impacts clinical and medical fields significantly, such as prenatal genetic screening, infectious disease monitoring, and companion diagnostics for targeted cancer therapy, etc. NGS is truly the cornerstone of building the exciting future of personalized medicine.
GenScript has now launched Next Generation Sequencing (NGS) Total Solutions on both oligo and probes synthesis and kits supply. This is powered by GenScript's strong expertise in de novo column and chip based DNA synthesis platform, as well as our strong R&D team on kits development. In addition, our total solutions kit includes all the necessary reagents for library preparation and target enrichment processes in NGS.